IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
This Quarter Return
+24.54%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
AUM
$278M
AUM Growth
+$278M
Cap. Flow
+$20M
Cap. Flow %
7.22%
Top 10 Hldgs %
51.21%
Holding
67
New
9
Increased
19
Reduced
11
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IFRX icon
51
InflaRx
IFRX
$117M
$869K 0.31%
+220,000
New +$869K
FGEN icon
52
FibroGen
FGEN
$48.4M
$845K 0.3%
19,700
INSM icon
53
Insmed
INSM
$30.3B
$801K 0.29%
33,600
-323,000
-91% -$7.7M
ARNA
54
DELISTED
Arena Pharmaceuticals Inc
ARNA
$749K 0.27%
16,500
MYGN icon
55
Myriad Genetics
MYGN
$633M
$680K 0.25%
25,000
AKCA
56
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
$536K 0.19%
31,723
SUPN icon
57
Supernus Pharmaceuticals
SUPN
$2.52B
$473K 0.17%
19,953
DERM
58
DELISTED
Dermira, Inc.
DERM
$454K 0.16%
30,000
MOR
59
DELISTED
MorphoSys AG American Depositary Shares
MOR
$402K 0.14%
+11,295
New +$402K
RDUS
60
DELISTED
Radius Health, Inc.
RDUS
$342K 0.12%
17,000
GTHX
61
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$296K 0.11%
11,200
ZEAL
62
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$188K 0.07%
+5,653
New +$188K
ANAB icon
63
AnaptysBio
ANAB
$630M
$163K 0.06%
10,000
CELG
64
DELISTED
Celgene Corp
CELG
-171,022
Closed -$17M
ARQL
65
DELISTED
Arqule Inc
ARQL
-41,000
Closed -$294K
ABMD
66
DELISTED
Abiomed Inc
ABMD
-11,700
Closed -$2.08M
RGEN icon
67
Repligen
RGEN
$6.54B
-24,000
Closed -$1.84M